These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10702494)

  • 1. Sequential use of paraformaldehyde and methanol as optimal conditions for the direct quantification of ZEBRA and rta antigens by flow cytometry.
    Imbert-Marcille BM; Coste-Burel M; Robillard N; Foucaud-Gamen J; Billaudel S; Drouet E
    Clin Diagn Lab Immunol; 2000 Mar; 7(2):206-11. PubMed ID: 10702494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and characterization of monoclonal antibodies specific for the R transactivator 185 of Epstein-Barr virus.
    Zhu YH; Wei YS; Li H; Liang WB; Du B; Zhang GQ; Zhang L
    J Virol Methods; 2007 Sep; 144(1-2):12-6. PubMed ID: 17532480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential paraformaldehyde and methanol fixation for simultaneous flow cytometric analysis of DNA, cell surface proteins, and intracellular proteins.
    Pollice AA; McCoy JP; Shackney SE; Smith CA; Agarwal J; Burholt DR; Janocko LE; Hornicek FJ; Singh SG; Hartsock RJ
    Cytometry; 1992; 13(4):432-44. PubMed ID: 1382010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the epstein-barr virus RTA protein in activation of distinct classes of viral lytic cycle genes.
    Ragoczy T; Miller G
    J Virol; 1999 Dec; 73(12):9858-66. PubMed ID: 10559298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
    Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
    Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway.
    Fahmi H; Cochet C; Hmama Z; Opolon P; Joab I
    J Virol; 2000 Jul; 74(13):5810-8. PubMed ID: 10846060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of antibodies to the Epstein-Barr virus immediate early gene product ZEBRA by a new enzyme-linked immunosorbent assay.
    Yamauchi Y; Tachiband Y; Maeda A; Wakiguchi H; Usui M; Kurata T; Sairenji T
    Intervirology; 1998; 41(6):278-84. PubMed ID: 10325538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A possible prognostic role of immunoglobulin-G antibody against recombinant Epstein-Barr virus BZLF-1 transactivator protein ZEBRA in patients with nasopharyngeal carcinoma.
    Yip TT; Ngan RK; Lau WH; Poon YF; Joab I; Cochet C; Cheng AK
    Cancer; 1994 Nov; 74(9):2414-24. PubMed ID: 7922994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum IgA antibodies to Epstein-Barr virus (EBV) early lytic antigens are present in primary EBV infection.
    Bhaduri-McIntosh S; Landry ML; Nikiforow S; Rotenberg M; El-Guindy A; Miller G
    J Infect Dis; 2007 Feb; 195(4):483-92. PubMed ID: 17230407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6.
    Flamand L; Stefanescu I; Ablashi DV; Menezes J
    J Virol; 1993 Nov; 67(11):6768-77. PubMed ID: 8411380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fixation of mammalian cells for flow cytometric evaluation of DNA content and nuclear immunofluorescence.
    Schimenti KJ; Jacobberger JW
    Cytometry; 1992; 13(1):48-59. PubMed ID: 1372202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme-linked immunosorbent assay for antibodies to ZEBRA, an Epstein-Barr trans-activator.
    Maréchal V; Meyohas MC; Joab I; Gaha S; Giot JF; Sergeant A; Nicolas JC
    Res Virol; 1993; 144(5):397-404. PubMed ID: 8284517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes.
    Pepperl S; Benninger-Döring G; Modrow S; Wolf H; Jilg W
    J Virol; 1998 Nov; 72(11):8644-9. PubMed ID: 9765404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked variation in response of consensus binding elements for the Rta protein of Epstein-Barr virus.
    Chen LW; Chang PJ; Delecluse HJ; Miller G
    J Virol; 2005 Aug; 79(15):9635-50. PubMed ID: 16014926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus (EBV) replicative gene expression in tumour cells of AIDS-related non-Hodgkin's lymphoma in relation to CD4 cell number and antibody titres to EBV.
    Brousset P; Drouet E; Schlaifer D; Icart J; Payen C; Meggetto F; Marchou B; Massip P; Delsol G
    AIDS; 1994 May; 8(5):583-90. PubMed ID: 7914731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid substitutions reveal distinct functions of serine 186 of the ZEBRA protein in activation of early lytic cycle genes and synergy with the Epstein-Barr virus R transactivator.
    Francis A; Ragoczy T; Gradoville L; Heston L; El-Guindy A; Endo Y; Miller G
    J Virol; 1999 Jun; 73(6):4543-51. PubMed ID: 10233912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of Epstein-Barr virus ZEBRA protein at its casein kinase 2 sites mediates its ability to repress activation of a viral lytic cycle late gene by Rta.
    El-Guindy AS; Miller G
    J Virol; 2004 Jul; 78(14):7634-44. PubMed ID: 15220438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response.
    Steven NM; Annels NE; Kumar A; Leese AM; Kurilla MG; Rickinson AB
    J Exp Med; 1997 May; 185(9):1605-17. PubMed ID: 9151898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct interactions of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta protein with the cellular protein octamer-1 and DNA are critical for specifying transactivation of a delayed-early promoter and stimulating viral reactivation.
    Carroll KD; Khadim F; Spadavecchia S; Palmeri D; Lukac DM
    J Virol; 2007 Aug; 81(16):8451-67. PubMed ID: 17537858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of Epstein-Barr virus reactivation in lymphoblastoid cells cultured in simulated microgravity.
    Long JP; Pierson S; Hughes JH
    In Vitro Cell Dev Biol Anim; 1999 Jan; 35(1):49-54. PubMed ID: 10475255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.